PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1420416
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1420416
According to the analysis by Fairfield Market Research, the global Surgical Simulation Market is anticipated to reach US$3 billion by 2031. Polymer-based revenue is expected to lead from 2024 to 2031.
Factors are Propelling Surgical Simulation Demand
The surge in medical simulation usage is primarily driven by its increasing application in healthcare, addressing a rise in mortality due to medical errors and a growing emphasis on enhancing patient safety outcomes. Virtual and augmented reality technologies are gaining popularity for education and communication in healthcare simulation, offering effective tools. For instance, virtual reality facilitates remote collaboration among students, enabling them to conduct operations and learn from their mistakes.
A paradigm shift in surgical treatments is evident, transitioning from traditional methods to minimally invasive surgeries. This includes mannequin-based core knowledge training, simulating first-hand surgical procedures. Minimally invasive techniques, with video assistance, provide heightened precision, reduced post-operative discomfort, fewer incisions, and minimal scarring, preserving natural organ structures.
The increasing prevalence of chronic illnesses worldwide, responsible for 71% of global fatalities, according to the World Health Organization, further fuels the demand for surgical simulators. As chronic illnesses become a growing health concern, particularly in Asian countries, healthcare professionals and academic institutions are increasingly seeking surgical simulators to meet the rising demand.
What region is expected to present the most significant opportunity in the surgical simulation market?
North America is poised to present the most substantial opportunity in the surgical simulation market during the projected period, with an estimated market size approaching US$ 1 billion by 2031. This prominence can be attributed to the region's commitment to reducing medical errors, the presence of prominent industry players, increased healthcare expenditures, ongoing technological advancements, and heightened government initiatives in the healthcare sector.
The North American region boasts the presence of key companies such as CAE Inc., Laerdal Medical, Gaumard Scientific Company, and Nasco HealthCare, making it the driving force behind the global healthcare simulation market's growth. Many healthcare simulation firms have a significant presence in this region to cater to the needs of academic institutions, research centers, and healthcare facilities.
Country-wise Analysis
The United States is poised to lead the surgical simulation market, demonstrating significant growth between 2024 and 2031. This growth is marked by a robust CAGR of 24.2%, resulting in a substantial market size. Additionally, the absolute dollar opportunity within this period is expected to be noteworthy.
The surgical simulation market in the United Kingdom is anticipated to exhibit substantial expansion, reaching a substantial market valuation by 2031. Over the course of 2024 to 2031, the market is expected to witness significant growth, with a remarkable CAGR. Moreover, there is a notable absolute dollar opportunity projected for this period.
Japan's surgical simulation market is on track for impressive growth, with a projected increase in market valuation by 2031. The market is expected to experience a notable CAGR during 2024 to 2031, accompanied by a substantial absolute dollar opportunity within this timeframe.
South Korea's surgical simulation market is set to expand, reaching a significant market value by 2031. During the period from 2024 to 2031, the market is projected to demonstrate substantial growth, driven by a noteworthy CAGR. Additionally, there is a substantial absolute dollar growth forecasted for this duration.
Key Companies Profiled
Market Segments Covered in Surgical Simulation Market Analysis
By Material Type
By Speciality
By End-use
By Region